Bayer completes refi as European loan volumes increase 22%
Pharmaceutical group Bayer has signed a Eu3.5bn revolving credit facility after the line was 70% oversubscribed, completing the fifth largest deal of the year so far as European syndicated lending continues to grow year on year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
